FDA Approved: STERITALC 2G — Original Application (Novatech SA)

View source ↗

Summary

FDA approved STERITALC 2G (talc) through an original NDA (NDA205555) submitted by Novatech SA for pleurodesis indications in the United States.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Effusion
• Pneumothorax

Drugs mentioned

• STERITALC 2G (TALC)

Snippet

ORIG AP for STERITALC 2G (TALC)